ARTICLE | Company News
Centocor's positive Remicade panel
July 12, 2000 7:00 AM UTC
The FDA's Arthritis Advisory Committee voted unanimously to recommend approval of Centocor's Remicade infliximab an anti-TNF-alpha antibody in combination with methotrexate to reduce joint damage in p...